Related Experiment Video
Updated: Jun 19, 2026

Modeling Multiple Sclerosis in the Two Sexes: MOG35-55-Induced Experimental Autoimmune Encephalomyelitis
Published on: October 13, 2023
Macrolide antibiotics aggravate experimental autoimmune encephalomyelitis and inhibit inducible nitric oxide synthase
Dunjing Wang1, Zhengqi Lu, Liping Hu
1Department of Neurology, The Third Affiliated hospital of Sun Yat-sen University, Guangzhou, China.
Abstract:
Recent studies have implicated Chlamydia pneumoniae (C. pneumoniae) is present in a subset of patients with multiple sclerosis (MS) in which C. pneumoniae could act as a cofactor in the development of the disease. Macrolide antibiotics are most widely used anti-chlamydial agents and have immunomodulatory effect independently of their anti-bacterial activity. To investigate their effects on experimental autoimmune encephalomyelitis (EAE), EAE was induced by immunization with MBP68-86 peptide emulsified in complete Freund's adjuvant (CFA). Clarithromycin (CM) or azithromycin (AM, 50 mg/100 g body weight) was administrated daily from day 2 before immunization. All rats developed and survived EAE, but the groups administrated CM or AM had more severe symptoms. On day 11 post-immunization, mononuclear cells (MNCs) were prepared from the spleen of control group and cultured with or without macrolide antibiotics (10mug/ml). We evaluated nitric oxide (NO) production in the serum and culture supernatant. Inducible nitric oxide synthase (iNOS) mRNA and protein expression in the spinal cords and cultured MNCs were measured. The results showed that CM and AM similarly inhibited NO production and iNOS mRNA and protein expression in vivo and in vitro. Macrolide antibiotics may aggravate EAE by inhibiting iNOS mRNA and protein expression. Further studies are needed to investigate the effect of macrolide antibiotics on MS and to compare the effect of different anti-chlamydial antibiotics on MS.
Insights
Macrolide antibiotics like clarithromycin and azithromycin may worsen experimental autoimmune encephalomyelitis (EAE) by inhibiting nitric oxide production. Further research is needed for multiple sclerosis (MS) patients.
Area of Science:
- Neuroimmunology
- Infectious Disease Immunology
Background:
- Chlamydia pneumoniae (C. pneumoniae) infection is implicated in multiple sclerosis (MS) pathogenesis.
- Macrolide antibiotics, used against C. pneumoniae, possess immunomodulatory properties.
- The impact of macrolides on autoimmune neurological conditions like experimental autoimmune encephalomyelitis (EAE) requires investigation.
Purpose of the Study:
- To investigate the effects of macrolide antibiotics (clarithromycin and azithromycin) on EAE, an animal model for MS.
- To determine the influence of these antibiotics on nitric oxide (NO) production and inducible nitric oxide synthase (iNOS) expression.
Main Methods:
- EAE was induced in rats using MBP68-86 peptide and CFA.
- Rats were treated daily with clarithromycin or azithromycin starting two days before immunization.
- Nitric oxide (NO) levels, iNOS mRNA, and protein expression were measured in spinal cords and cultured mononuclear cells (MNCs).
Main Results:
- Macrolide administration did not prevent EAE development but led to more severe symptoms.
- Both clarithromycin and azithromycin significantly inhibited NO production in vivo and in vitro.
- Inhibition of iNOS mRNA and protein expression was observed in both serum and cultured MNCs.
Conclusions:
- Macrolide antibiotics may exacerbate EAE by suppressing iNOS expression and NO production.
- These findings suggest a potential negative impact of macrolides in the context of MS.
- Further studies are warranted to explore the role of macrolides and other anti-chlamydial agents in MS management.
More Related Videos
08:17Scoring Central Nervous System Inflammation, Demyelination, and Axon Injury in Experimental Autoimmune Encephalomyelitis
Published on: February 23, 2024
08:03Myelin Oligodendrocyte Glycoprotein (MOG35-55) Induced Experimental Autoimmune Encephalomyelitis (EAE) in C57BL/6 Mice
Published on: April 15, 2014
Related Concept Videos
Nitric Oxide Signaling Pathway
Inhibitors of Bacterial Protein Synthesis
Encephalitis ll: Pathophysiology